Physician profile
Howard B Miller
NPI 1093883951
$1,247.40
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $267 · 2021: $513 · 2022: $273.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $438.30 | 2021-2022 | |
| Abbvie INC. | $113.44 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $112.19 | 2019-2020 | |
| Clarus Therapeutics INC. | $94.90 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $85.97 | 2019-2020 | |
| Amarin Pharma, INC. | $82.78 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $47.13 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $41.91 | 2019-2021 | |
| Eisai INC. | $40.43 | 2020-2021 | |
| Allergan, INC. | $38.61 | 2020 | |
| Esperion Therapeutics, INC. | $36.54 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.87 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $23.75 | 2019 | |
| Astellas Pharma US INC | $23.55 | 2019 | |
| Lilly USA, LLC | $16.45 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.58 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.